Snowball logo
logo
6004

KPC Pharmaceuticals Inc

600422 SHG
¥8.22-¥0.19  (2.26%)
Estimate
EPS
-0.28
Beta
-0.15
Growth
Revenue, YoY
-53.7%
Net income, YoY
-305.95%
FCF, YoY
-75.17%
Forecast
P/E (FWD)
18.4
EPS (FWD)
0.447
About the company
Ticker
600422
ISIN
CNE0000015P8
Country
China
Sector (GICS)
Healthcare
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as well as engages in the wholesale and retail of medicines and equipment. The company offers products in the field of cardiovascular and cerebrovascular, orthopedics series, antimalarial, gynecology, digestive system, and others treatments. It offers its products under Luotai, Tianxuanqing, Artemedine, Artem, and Arco brands. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals,Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

Frequently asked questions

What sector does KPC Pharmaceuticals Inc (600422) operate in?

KPC Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is KPC Pharmaceuticals Inc (600422) current stock price?

As of the latest data, KPC Pharmaceuticals Inc stock price is CN¥8.22, with a previous close of CN¥8.41. KPC Pharmaceuticals Inc lost -CN¥0.19 in the last trading session, representing a -2.26% loss.

What is KPC Pharmaceuticals Inc (600422) current market capitalization?

KPC Pharmaceuticals Inc market cap is approximately 6.22 billion.

What is KPC Pharmaceuticals Inc (600422) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.28, and the forward EPS is CN¥0.45.

Does KPC Pharmaceuticals Inc (600422) pay dividends?

No. KPC Pharmaceuticals Inc does not pay a dividend.

What is KPC Pharmaceuticals Inc (600422) beta (volatility) score?

KPC Pharmaceuticals Inc has a beta of -0.150, indicating lower volatility than the overall market.